INOVIQ Ltd (ASX:IIQ)
0.3950
+0.0100 (2.60%)
Aug 1, 2025, 4:10 PM AEST
INOVIQ Revenue
INOVIQ had revenue of 828.43K AUD in the half year ending December 31, 2024, with 403.94% growth. This brings the company's revenue in the last twelve months to 1.69M, down -19.11% year-over-year. In the fiscal year ending June 30, 2024, INOVIQ had annual revenue of 1.56M with 0.67% growth.
Revenue (ttm)
1.69M
Revenue Growth
-19.11%
P/S Ratio
26.11
Revenue / Employee
112.60K
Employees
15
Market Cap
44.09M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 1.56M | 10.36K | 0.67% |
Jun 30, 2023 | 1.55M | -446.01K | -22.33% |
Jun 30, 2022 | 2.00M | 726.44K | 57.16% |
Jun 30, 2021 | 1.27M | 735.67K | 137.48% |
Jun 30, 2020 | 535.10K | 14.30K | 2.75% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |